Home > Boards > US Listed > Medical - Healthcare > Acasti Pharma, Inc (ACST)

What is Chen Buying? What is Chen Selling?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
JB3729 Member Profile
 
Followed By 83
Posts 3,868
Boards Moderated 0
Alias Born 02/15/10
160x600 placeholder
Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference GlobeNewswire Inc. - 1/3/2022 8:30:00 AM
Acasti Pharma jumps 21% on new Outperform rating at Oppenheimer with PT of $6 Seeking Alpha - 12/22/2021 7:16:57 AM
Acasti says candidate for subarachnoid hemorrhage met main goals in pivotal PK study Seeking Alpha - 12/2/2021 7:40:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/2/2021 7:17:49 AM
Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104 GlobeNewswire Inc. - 12/2/2021 7:00:00 AM
Acasti Pharma CEO to Participate in the Benzinga All Access Event on December 2nd GlobeNewswire Inc. - 11/24/2021 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/16/2021 4:21:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/16/2021 4:21:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/16/2021 4:20:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/16/2021 4:20:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/16/2021 4:19:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/16/2021 4:17:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 6:07:42 AM
Acasti Pharma Announces Annual Stock Option Grants GlobeNewswire Inc. - 11/12/2021 5:34:47 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/10/2021 7:24:49 AM
Acasti Pharma EPS beats by $0.60 Seeking Alpha - 11/10/2021 7:20:59 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/10/2021 7:09:48 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2021 7:02:37 AM
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022 GlobeNewswire Inc. - 11/10/2021 7:00:00 AM
Acasti Pharma Q2 Earnings Preview Seeking Alpha - 11/9/2021 1:07:09 PM
Notable earnings before Wednesday's open Seeking Alpha - 11/9/2021 11:17:08 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 11/5/2021 4:08:33 PM
Acasti Pharma Schedules Second Quarter Fiscal 2022 Business Update Conference Call GlobeNewswire Inc. - 11/4/2021 8:30:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/3/2021 4:34:21 PM
Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan GlobeNewswire Inc. - 10/6/2021 8:30:00 AM
JB3729   Wednesday, 07/31/19 08:35:52 AM
Re: None
Post # of 1116 

What is Chen Buying? What is Chen Selling?
Letter 2195
July 22, 2019

Update:

Last week was a big week for me, not only silver did great, my Neptune Wellness Solutions Inc. (NEPT) and Acasti Pharma Inc. (ACST) both exploded. NEPT did a financing with mostly large shareholders and insiders. Remember shorts were all over NEPT as they smell blood of a raise. Before I left for vacation, I asked large shareholders of NEPT to consider doing a financing at a small premium to send the shorts a strong message. I am very pleased to see this 4.4 financing mostly by large shareholders and insiders. My friend George Haywood called it “the most impressive insider buying I have ever seen!“ You can see from the filing, Perceptive increased its stake to 15%, CEO and Chairman put in 5 million despite they already owned millions of shares. Every large shareholders participated including my friend Haywood et al. Plus this financing comes with conditions that the buyers can't sell any shares, exisitng or new for months to come. Basically the shorts are in a box and getting ready to be squeezed hard. We should have very exciting news coming starting with closing the US plant this month.

ACST is doing great thanks to a new research report Oppenheimer came out. It gave 7 dollar target assuming 30% chance of success. Personally I believe the chance of success is more close to 90%. As I discussed, tens millions of shares will likely be purchased before the data readout in December. I am holding my shares here. If you don't wish to take any risks, you can sell some before the data and make it zero cost into the data, which is likely coming out in December.


Regards,
Chen


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences